A detailed history of Kpp Advisory Services LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kpp Advisory Services LLC holds 235 shares of REGN stock, worth $167,935. This represents 0.06% of its overall portfolio holdings.

Number of Shares
235
Previous 235 -0.0%
Holding current value
$167,935
Previous $247 Million 0.02%
% of portfolio
0.06%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 27, 2024

SELL
$883.2 - $1071.19 $3,532 - $4,284
-4 Reduced 1.67%
235 $247 Million
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $3,610 - $3,973
-4 Reduced 1.65%
239 $230 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $188,368 - $214,253
243 New
243 $213 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Kpp Advisory Services LLC Portfolio

Follow Kpp Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kpp Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kpp Advisory Services LLC with notifications on news.